Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

Press releases published on November 12, 2026

11 hours ago

Rally Report 2026: The momentum is growing. But too many girls are still being left behind

Indeterminate GlobeNewswire

11 hours ago

Le signal de ralliement 2026 : L’élan prend de l’ampleur, mais trop de filles sont encore laissées en plan

Indeterminate GlobeNewswire

11 hours ago

Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED

Indeterminate GlobeNewswire

11 hours ago

Theriva™ Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results

Indeterminate GlobeNewswire

11 hours ago

IMUNON Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

11 hours ago

Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress

Indeterminate GlobeNewswire

11 hours ago

Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

11 hours ago

Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

11 hours ago

Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation

Indeterminate GlobeNewswire

11 hours ago

Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects

Indeterminate GlobeNewswire

11 hours ago

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London

Indeterminate GlobeNewswire

11 hours ago

R1 Takes Aim at Healthcare’s Fragmented Revenue Cycle with Six Connected AI Solutions

Indeterminate GlobeNewswire

12 hours ago

Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials

Indeterminate GlobeNewswire

12 hours ago

123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health

Indeterminate GlobeNewswire

12 hours ago

Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale

Indeterminate GlobeNewswire

12 hours ago

Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

12 hours ago

Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3

Indeterminate GlobeNewswire

12 hours ago

Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

12 hours ago

Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

12 hours ago

Altimmune Announces Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire